The skinny on slug

Molecular Carcinogenesis

Volumn 49, Issue 10, 2010, Pages 851-861

  Shirley, Stephanie H ^a   Hudson, Laurie G ^b   He, Jing ^a   Kusewitt, Donna F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Skin; Skin neoplasms; Snail family transcription factors; Ultraviolet rays; Wound healing

Indexed keywords

TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CELL INTERACTION; ELECTRODERMAL RESPONSE; EPITHELIZATION; GENE TARGETING; HAIR FOLLICLE; HAIR GROWTH; HOMEOSTASIS; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SKIN CANCER; SKIN CARCINOGENESIS; SPINDLE CELL; SUNBURN; WOUND HEALING; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; EPIDERMIS; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

GASTROPODA;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; EPIDERMIS; KERATINOCYTES; MICE; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 77958149240     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20674     Document Type: Article

References (129)

1. Simpson P. Maternal-zygotic gene interactions during formation of the dorsoventral pattern in drosophila embryos. Genetics 1983; 105: 615-632.
2. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005; 132: 3151-3161.
3. Barrallo-Gimeno A, Nieto MA. Evolutionary history of the Snail/Scratch superfamily. Trends Genet 2009; 25: 248-252.
4. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166.
5. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995; 154: 8-20.
6. Nawshad A, Lagamba D, Polad A, Hay ED. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005; 179: 11-23.
7. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
8. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558.
9. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-6969.
10. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
11. Arnoux V, Come C, Kusewitt DF, Hudson LG, Savagner P. Cutaneous wound reepithelialization: A partial and reversible EMT. In: Savagner P, editor. Rise and fall of epithelial phenotype: Concepts of epithelial-mesenchymal transition. New York: Kluwer/Plenum; 2005. pp. 111-134.
12. Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: Slowly going into the fast lane of development and cancer. Gene 2000; 257: 1-12.
13. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-746.
14. Rhim H, Savagner P, Thibaudeau G, Thiery JP, Pavan WJ. Localization of a neural crest transcription factor, Slug, to mouse chromosome 16 and human chromosome 8. Mamm Genome 1997; 8: 872-873.
15. Cohen ME, Yin M, Paznekas WA, Schertzer M, Wood S, Jabs EW. Human SLUG gene organization, expression, and chromosome map location on 8q. Genomics 1998; 51: 468-471.
16. Jiang R, Norton CR, Copeland NG, Gilbert DJ, Jenkins NA, Gridley T. Genomic organization, expression and chromosomal localization of the mouse Slug (Slugh) gene. Biochim Biophys Acta 1998; 1443: 251-254.
17. Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT. Human Slug is a repressor that localizes to sites of active transcription. Mol Cell Biol 2000; 20: 5087-5095.
18. Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol 1996; 16: 6263-6272.
19. Sefton M, Sanchez S, Nieto MA. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 1998; 125: 3111-3121.
20. Mingot JM, Vega S, Maestro B, Sanz JM, Nieto MA. Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors. J Cell Sci 2009; 122: 1452-1460.
21. Yamasaki H, Sekimoto T, Ohkubo T, et al. Zinc finger domain of Snail functions as a nuclear localization signal for importin beta-mediated nuclear import pathway. Genes Cells 2005; 10: 455-464.
22. Ko H, Kim HS, Kim NH, et al. Nuclear localization signals of the E-cadherin transcriptional repressor Snail. Cells Tissues Organs 2007; 185: 66-72.
23. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
24. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89.
25. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
26. Inukai T, Inoue A, Kurosawa H, et al. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 1999; 4: 343-352.
27. Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278.
28. Come C, Arnoux V, Bibeau F, Savagner P. Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia 2004; 9: 183-193.
29. Tripathi MK, Misra S, Khedkar SV, et al. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. J Biol Chem 2005; 280: 17163-17171.
30. Mittal MK, Myers JN, Misra S, Bailey CK, Chaudhuri G. In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 2008; 372: 30-34.
31. Bailey CK, Misra S, Mittal MK, Chaudhuri G. Human SLUG does not directly bind to CtBP1. Biochem Biophys Res Commun 2007; 353: 661-664.
32. Vernon AE, LaBonne C. Tumor metastasis: A new twist on epithelial-mesenchymal transitions. Curr Biol 2004; 14: R719-R721.
33. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 2005; 280: 11740-11748.
34. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940.
35. Zhou BP, Hung MC. Wnt, hedgehog and snail: Sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis. Cell Cycle 2005; 4: 772-776.
36. Wang SP, Wang WL, Chang YL, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11: 694-704.
37. Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005; 24: 3446-3458.
38. Peinado H, Moreno-Bueno G, Hardisson D, et al. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res 2008; 68: 4541-4550.
39. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A. Alcohol stimulates activation of snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells. Alcohol Clin Exp Res 2010; 34: 19-31.
40. Parent AE, Newkirk KM, Kusewitt DF. Slug (Snai2) expression during skin and hair follicle development. J Invest Dermatol 2010; 130: 1737-1739.
41. Parent AE, Choi C, Caudy K, Gridley T, Kusewitt DF. The developmental transcription factor slug is widely expressed in tissues of adult mice. J Histochem Cytochem 2004; 52: 959-965.
42. Jamora C, Lee P, Kocieniewski P, et al. A signaling pathway involving TGF-beta2 and snail in hair follicle morphogenesis. PLoS Biol 2005; 3: e11.
43. Franci C, Takkunen M, Dave N, et al. Expression of Snail protein in tumor-stroma interface. Oncogene 2006; 25: 5134-5144.
44. Newkirk KM, Parent AE, Fossey SL, et al. Snai2 expression enhances ultraviolet radiation-induced skin carcinogenesis. Am J Pathol 2007; 171: 1629-1639.
45. Perez-Mancera PA, Gonzalez-Herrero I, Maclean K, et al. SLUG (SNAI2) overexpression in embryonic development. Cytogenet Genome Res 2006; 114: 24-29.
46. Murray SA, Gridley T. Snail1 gene function during early embryo patterning in mice. Cell Cycle 2006; 5: 2566-2570.
47. Savagner P, Kusewitt DF, Carver EA, et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 2005; 202: 858-866.
48. Hudson LG, Newkirk KM, Chandler HL, et al. Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2). J Dermatol Sci 2009; 56: 19-26.
49. Turner FE, Broad S, Khanim FL, et al. Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J Biol Chem 2006; 281: 21321-21331.
50. Cobaleda C, Perez-Caro M, Vicente-Duenas C, Sanchez-Garcia I. Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu Rev Genet 2007; 41: 41-61.
51. Kusewitt DF, Choi C, Newkirk KM, et al. Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization. J Invest Dermatol 2009; 129: 491-495.
52. Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008; 19: 4738-4749.
53. Zavadil J, Bitzer M, Liang D, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 2001; 98: 6686-6691.
54. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-1165.
55. Hoot KE, Lighthall J, Han G, et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 2008; 118: 2722-2732.
56. Ikuta T, Kawajiri K. Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp Cell Res 2006; 312: 3585-3594.
57. Hudson LG, Choi C, Newkirk KM, et al. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol Carcinog 2007; 46: 257-268.
58. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation. Am J Pathol 1998; 152: 135-144.
59. Chan AO, Wong BC, Lan HY, et al. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol 2003; 18: 534-539.
60. Kato Y, Hirano T, Yoshida K, et al. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Lung Cancer 2005; 48: 323-330.
61. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 2003; 116: 499-511.
62. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-1618.
63. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001; 21: 8184-8188.
64. Come C, Magnino F, Bibeau F, et al. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 2006; 12: 5395-5402.
65. Uchikado Y, Natsugoe S, Okumura H, et al. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2005; 11: 1174-1180.
66. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005; 129: 1375-1383.
67. Elloul S, Silins I, Trope CG, Benshushan A, Davidson B, Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 2006; 449: 520-528.
68. Alves CC, Carneiro F, Hoefler H, Becker KF. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci 2009; 14: 3035-3050.
69. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005; 12: 488-496.
70. Shioiri M, Shida T, Koda K, et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006; 94: 1816-1822.
71. Sivertsen S, Hadar R, Elloul S, et al. Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer 2006; 54: 309-317.
72. Joseph MJ, Dangi-Garimella S, Shields MA, et al. Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem 2009; 108: 726-736.
73. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137: 1403-1419.
74. Newkirk KM, MacKenzie DA, Bakaletz AP, Hudson LG, Kusewitt DF. Microarray analysis demonstrates a role for Slug in epidermal homeostasis. J Invest Dermatol 2008; 128: 361-369.
75. Tripathi MK, Misra S, Chaudhuri G. Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells. Biochem Biophys Res Commun 2005; 329: 508-515.
76. Brock J, McCluskey J, Baribault H, Martin P. Perfect wound healing in the keratin 8 deficient mouse embryo. Cell Motil Cytoskeleton 1996; 35: 358-366.
77. Casanova ML, Bravo A, Martinez-Palacio J, et al. Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice. FASEB J 2004; 18: 1556-1558.
78. Larcher F, Bauluz C, Diaz-Guerra M, et al. Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomas. Mol Carcinog 1992; 6: 112-121.
79. Coulombe PA, Tong X, Mazzalupo S, Wang Z, Wong P. Great promises yet to be fulfilled: Defining keratin intermediate filament function in vivo. Eur J Cell Biol 2004; 83: 735-746.
80. DePianto D, Coulombe PA. Intermediate filaments and tissue repair. Exp Cell Res 2004; 301: 68-76.
81. McGowan K, Coulombe PA. The wound repair-associated keratins 6, 16 and 17. Insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture. Subcell Biochem 1998; 31: 173-204.
82. Moll R, Divo M, Langbein L. The human keratins: Biology and pathology. Histochem Cell Biol 2008; 129: 705-733.
83. Paladini RD, Takahashi K, Bravo NS, Coulombe PA. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J Cell Biol 1996; 132: 381-397.
84. Tomic-Canic M, Komine M, Freedberg IM, Blumenberg M. Epidermal signal transduction and transcription factor activation in activated keratinocytes. J Dermatol Sci 1998; 17: 167-181.
85. Usui ML, Underwood RA, Mansbridge JN, Muffley LA, Carter WG, Olerud JE. Morphological evidence for the role of suprabasal keratinocytes in wound reepithelialization. Wound Repair Regen 2005; 13: 468-479.
86. Stojadinovic O, Pastar I, Vukelic S, et al. Deregulation of keratinocyte differentiation and activation: A hallmark of venous ulcers. J Cell Mol Med 2008; 12: 2675-2690.
87. Has C, Bruckner-Tuderman L. Molecular and diagnostic aspects of genetic skin fragility. J Dermatol Sci 2006; 44: 129-144.
88. Baum CL, Arpey CJ. Normal cutaneous wound healing: Clinical correlation with cellular and molecular events. Dermatol Surg 2005; 31: 674-686, discussion 686.
89. Coulombe PA. Wound epithelialization: Accelerating the pace of discovery. J Invest Dermatol 2003; 121: 219-230.
90. Li W, Dasgeb B, Phillips T, et al. Wound-healing perspectives. Dermatol Clin 2005; 23: 181-192.
91. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 2005; 304: 274-286.
92. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
93. Carretero M, Escamez MJ, Garcia M, et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 2008; 128: 223-236.
94. Greenhalgh DG. Models of wound healing. J Burn Care Rehabil 2005; 26: 293-305.
95. Stoscheck CM, Nanney LB, King LE, Jr. Quantitative determination of EGF-R during epidermal wound healing. J Invest Dermatol 1992; 99: 645-649.
96. Wenczak BA, Lynch JB, Nanney LB. Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J Clin Invest 1992; 90: 2392-2401.
97. Chernoff EA, Robertson S. Epidermal growth factor and the onset of epithelial epidermal wound healing. Tissue Cell 1990; 22: 123-135.
98. Andree C, Swain WF, Page CP, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 1994; 91: 12188-12192.
99. Hudson LG, McCawley LJ. Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc Res Tech 1998; 43: 444-455.
100. Draper BK, Komurasaki T, Davidson MK, Nanney LB. Epiregulin is more potent than EGF or TGFalpha in promoting in vitro wound closure due to enhanced ERK/MAPK activation. J Cell Biochem 2003; 89: 1126-1137.
101. Li Y, Fan J, Chen M, Li W, Woodley DT. Transforming growth factor-alpha: A major human serum factor that promotes human keratinocyte migration. J Invest Dermatol 2006; 126: 2096-2105.
102. Shirakata Y, Kimura R, Nanba D, et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 2005; 118: 2363-2370.
103. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23: 912-923.
104. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
105. De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005; 65: 6237-6244.
106. Makinen M, Stenback F. Skin tumor development and keratin expression in different experimental models. Relation to inducing agent and target tissue structure. Exp Toxicol Pathol 1998; 50: 199-208.
107. Klein-Szanto AJ, Larcher F, Bonfil RD, Conti CJ. Multistage chemical carcinogenesis protocols produce spindle cell carcinomas of the mouse skin. Carcinogenesis 1989; 10: 2169-2172.
108. Franz M, Spiegel K, Umbreit C, et al. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem Cell Biol 2009; 131: 651-660.
109. Portella G, Liddell J, Crombie R, et al. Molecular mechanisms of invasion and metastasis during mouse skin tumour progression. Invasion Metastasis 1994; 14: 7-16.
110. Caulin C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 1995; 6: 1027-1035.
111. Portella G, Cumming SA, Liddell J, et al. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion. Cell Growth Differ 1998; 9: 393-404.
112. Cui W, Fowlis DJ, Bryson S, et al. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86: 531-542.
113. Fraga MF, Herranz M, Espada J, et al. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 2004; 64: 5527-5534.
114. Olmeda D, Jorda M, Peinado H, Fabra A, Cano A. Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 2007; 26: 1862-1874.
115. Olmeda D, Montes A, Moreno-Bueno G, Flores JM, Portillo F, Cano A. Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene 2008; 27: 4690-4701.
116. Miyoshi A, Kitajima Y, Sumi K, et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 2004; 90: 1265-1273.
117. Sun L, Diamond ME, Ottaviano AJ, Joseph MJ, Ananthanarayan V, Munshi HG. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 2008; 6: 10-20.
118. Fabre-Guillevin E, Malo M, Cartier-Michaud A, et al. PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Breast Cancer Res 2008; 10: R100.
119. Yokoyama K, Kamata N, Fujimoto R, et al. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 2003; 22: 891-898.
120. Zheng G, Lyons JG, Tan TK, et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 2009; 175: 580-591.
121. Shibata S, Marushima H, Asakura T, et al. Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Int J Oncol 2009; 34: 1433-1448.
122. Newkirk KM, Duncan FJ, Brannick EM, Chandler HL, Parent AE, Kusewitt DF. The acute cutaneous inflammatory response is attenuated in Slug-knockout mice. Lab Invest 2008; 88: 831-841.
123. Mann JR, Backlund MG, Buchanan FG, et al. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res 2006; 66: 6649-6656.
124. Yang L, Amann JM, Kikuchi T, et al. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Cancer Res 2007; 67: 5587-5593.
125. Backlund MG, Mann JR, Holla VR, et al. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer. Cancer Res 2008; 68: 9331-9337.
126. Hugo HJ, Wafai R, Blick T, Thompson EW, Newgreen DF. Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction-A model for cross-modulation. BMC Cancer 2009; 9: 235.
127. Moreno-Bueno G, Cubillo E, Sarrio D, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006; 66: 9543-9556.
128. Zidar N, Gale N, Kojc N, et al. Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch 2008; 453: 267-274.
129. Franci C, Gallen M, Alameda F, et al. Snail1 protein in the stroma as a new putative prognosis marker for colon tumours. PLoS One 2009; 4: e5595.